Compare VET & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VET | BHVN |
|---|---|---|
| Founded | 1994 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | 2017 |
| Metric | VET | BHVN |
|---|---|---|
| Price | $8.13 | $10.89 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $29.79 |
| AVG Volume (30 Days) | 1.6M | ★ 3.1M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,445,514,003.00 | N/A |
| Revenue This Year | $9.23 | N/A |
| Revenue Next Year | N/A | $2,219.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.48 | N/A |
| 52 Week Low | $5.14 | $7.48 |
| 52 Week High | $10.49 | $44.28 |
| Indicator | VET | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 50.98 |
| Support Level | $7.95 | $10.69 |
| Resistance Level | $9.28 | $11.80 |
| Average True Range (ATR) | 0.33 | 0.74 |
| MACD | -0.15 | 0.26 |
| Stochastic Oscillator | 12.54 | 74.08 |
Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, development, and optimization of producing properties in North America, Europe, and Australia. The majority of Vermilion's revenue is derived from the production and sale of petroleum and natural gas. In each market, the company relies on a host of drilling and well-completion techniques to keep production at attractive levels. Geographically, the company derives majority of its revenue from Canada.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.